Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 3/20 | 0.47 |
| ▸ | CTSK | P43235 | 3/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.47 |
| ▸ | BACE1 | P56817 | 4/20 | 0.46 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 2/20 | 0.46 |
| ▸ | AKT1 | P31749 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8612019 | 0.89 | ANPEP (0.47) | CA12CA1CA7CA14ATM | |
| SCHEMBL8613638 | 0.88 | CA2 (0.52) | CTSSCTSKCTSLCTSBKLK5 | |
| SCHEMBL9411102 | 0.86 | CYP3A4 (0.53) | — | |
| SCHEMBL17848995 | 0.84 | MEP1B (0.47) | CA12CA1CA7CA14ATM | |
| SCHEMBL7314443 | 0.83 | CTSK (0.48) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL7313867 | 0.83 | CTSK (0.48) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL4750042 | 0.82 | CTSS (0.61) | CTSSCTSKBACE1 | |
| SCHEMBL9229164 | 0.80 | SDCBP (0.48) | CTSSCTSK | |
| SCHEMBL7299787 | 0.80 | PSEN1 (0.59) | BACE1KLK5 | |
| SCHEMBL8617454 | 0.79 | CA2 (0.51) | CTSSCTSKCTSLCTSBCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041064-A2 | N-substituted alpha aminoacid amides as calcium channel modulators | ELI LILLY AND COMPANY LIMITED (GB) | 2000-10-04 | — | — | EP | disclosed |
| EP-0805147-A1 | Novel N-substituted alpha aminoacid amides as calcium channel modulators | LILLY INDUSTRIES LIMITED (GB) | 1997-11-05 | — | — | EP | disclosed |